3988 related articles for article (PubMed ID: 18677098)
1. ATF2: a transcription factor that elicits oncogenic or tumor suppressor activities.
Bhoumik A; Ronai Z
Cell Cycle; 2008 Aug; 7(15):2341-5. PubMed ID: 18677098
[TBL] [Abstract][Full Text] [Related]
2. ATF2 - at the crossroad of nuclear and cytosolic functions.
Lau E; Ronai ZA
J Cell Sci; 2012 Jun; 125(Pt 12):2815-24. PubMed ID: 22685333
[TBL] [Abstract][Full Text] [Related]
3. A Transcriptionally Inactive ATF2 Variant Drives Melanomagenesis.
Claps G; Cheli Y; Zhang T; Scortegagna M; Lau E; Kim H; Qi J; Li JL; James B; Dzung A; Levesque MP; Dummer R; Hayward NK; Bosenberg M; Brown KM; Ronai ZA
Cell Rep; 2016 May; 15(9):1884-92. PubMed ID: 27210757
[TBL] [Abstract][Full Text] [Related]
4. PKCε promotes oncogenic functions of ATF2 in the nucleus while blocking its apoptotic function at mitochondria.
Lau E; Kluger H; Varsano T; Lee K; Scheffler I; Rimm DL; Ideker T; Ronai ZA
Cell; 2012 Feb; 148(3):543-55. PubMed ID: 22304920
[TBL] [Abstract][Full Text] [Related]
5. ATF2 on the double - activating transcription factor and DNA damage response protein.
Bhoumik A; Lopez-Bergami P; Ronai Z
Pigment Cell Res; 2007 Dec; 20(6):498-506. PubMed ID: 17935492
[TBL] [Abstract][Full Text] [Related]
6. The activating transcription factor 2: an influencer of cancer progression.
Huebner K; Procházka J; Monteiro AC; Mahadevan V; Schneider-Stock R
Mutagenesis; 2019 Dec; 34(5-6):375-389. PubMed ID: 31799611
[TBL] [Abstract][Full Text] [Related]
7. Critical role of N-terminal end-localized nuclear export signal in regulation of activating transcription factor 2 (ATF2) subcellular localization and transcriptional activity.
Hsu CC; Hu CD
J Biol Chem; 2012 Mar; 287(11):8621-32. PubMed ID: 22275354
[TBL] [Abstract][Full Text] [Related]
8. Activating transcription factor 2-derived peptides alter resistance of human tumor cell lines to ultraviolet irradiation and chemical treatment.
Bhoumik A; Ivanov V; Ronai Z
Clin Cancer Res; 2001 Feb; 7(2):331-42. PubMed ID: 11234888
[TBL] [Abstract][Full Text] [Related]
9. Subcellular localization of activating transcription factor 2 in melanoma specimens predicts patient survival.
Berger AJ; Kluger HM; Li N; Kielhorn E; Halaban R; Ronai Z; Rimm DL
Cancer Res; 2003 Dec; 63(23):8103-7. PubMed ID: 14678960
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of melanoma growth by small molecules that promote the mitochondrial localization of ATF2.
Varsano T; Lau E; Feng Y; Garrido M; Milan L; Heynen-Genel S; Hassig CA; Ronai ZA
Clin Cancer Res; 2013 May; 19(10):2710-22. PubMed ID: 23589174
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-451 regulates activating transcription factor 2 expression and inhibits liver cancer cell migration.
Lv G; Hu Z; Tie Y; Du J; Fu H; Gao X; Zheng X
Oncol Rep; 2014 Sep; 32(3):1021-8. PubMed ID: 24968707
[TBL] [Abstract][Full Text] [Related]
12. The transcription factor ATF2 promotes melanoma metastasis by suppressing protein fucosylation.
Lau E; Feng Y; Claps G; Fukuda MN; Perlina A; Donn D; Jilaveanu L; Kluger H; Freeze HH; Ronai ZA
Sci Signal; 2015 Dec; 8(406):ra124. PubMed ID: 26645581
[TBL] [Abstract][Full Text] [Related]
13. The roles of ATF2 (activating transcription factor 2) in tumorigenesis.
Gozdecka M; Breitwieser W
Biochem Soc Trans; 2012 Feb; 40(1):230-4. PubMed ID: 22260696
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of tumor necrosis factor alpha expression by activating transcription factor 2 increases UVC-induced apoptosis of late-stage melanoma cells.
Ivanov VN; Ronai Z
J Biol Chem; 1999 May; 274(20):14079-89. PubMed ID: 10318823
[TBL] [Abstract][Full Text] [Related]
15. Activating transcription factor 2 in mesenchymal tumors.
Endo M; Su L; Nielsen TO
Hum Pathol; 2014 Feb; 45(2):276-84. PubMed ID: 24289970
[TBL] [Abstract][Full Text] [Related]
16. ATF2 confers radiation resistance to human melanoma cells.
Ronai Z; Yang YM; Fuchs SY; Adler V; Sardana M; Herlyn M
Oncogene; 1998 Jan; 16(4):523-31. PubMed ID: 9484842
[TBL] [Abstract][Full Text] [Related]
17. In this issue--oncogenes, tumor suppressor genes and melanocytic lesions.
Udey MC; Hornyak TJ
J Invest Dermatol; 2004 May; 122(5):VII-VIII. PubMed ID: 15140248
[No Abstract] [Full Text] [Related]
18. Sensitisation of c-MYC-induced B-lymphoma cells to apoptosis by ATF2.
Walczynski J; Lyons S; Jones N; Breitwieser W
Oncogene; 2014 Feb; 33(8):1027-36. PubMed ID: 23416976
[TBL] [Abstract][Full Text] [Related]
19. Preclinical studies of celastrol and acetyl isogambogic acid in melanoma.
Abbas S; Bhoumik A; Dahl R; Vasile S; Krajewski S; Cosford ND; Ronai ZA
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6769-78. PubMed ID: 18006779
[TBL] [Abstract][Full Text] [Related]
20. TIP49b, a regulator of activating transcription factor 2 response to stress and DNA damage.
Cho SG; Bhoumik A; Broday L; Ivanov V; Rosenstein B; Ronai Z
Mol Cell Biol; 2001 Dec; 21(24):8398-413. PubMed ID: 11713276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
